Concepedia

Teresa Brevini

TB

9

Publications

2.1K

Citations

9

H-Index

1998

Active since

Affiliations

Wellcome/MRC Cambridge Stem Cell Institute(Current)

University of Cambridge

Cambridge University Hospitals NHS Foundation Trust

Wellcome Sanger Institute

Addenbrooke's Hospital

Teresa Brevini is an author at Wellcome/MRC Cambridge Stem Cell Institute specializing in medicine, cell biology, and organoids.

ORCID

Top concepts

Publications per year

1998–2023

9

Publications

9

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Bo Meng, Adam Abdullahi, Isabella A.T.M. Ferreira et al. · Nature · 2022 · 1.1K citations · Full text

Cholangiocyte organoids can repair bile ducts after transplantation in the human liver

Fotios Sampaziotis, Daniele Muraro, Olivia Tysoe et al. · Science · 2021 · 348 citations · Full text

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

Teresa Brevini, Mailis Maes, Gwilym J. Webb et al. · Nature · 2022 · 282 citations · Full text

Isolation and propagation of primary human cholangiocyte organoids for the generation of bioengineered biliary tissue

Olivia Tysoe, Alexander W. Justin, Teresa Brevini et al. · Nature Protocols · 2019 · 114 citations · Full text

, , +11

SARS-CoV-2 Omicron spike mediated immune escape and tropism shift

Bo Meng, Isabella A.T.M. Ferreira, Adam Abdullahi et al. · 2021 · 63 citations · Full text

, , +13

Rows per page

1–5 of 9